What is the Fiscal Year for Inventiva Pharma?
Date: November 14, 2026
Inventiva Pharma's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
France
Industry
Biotechnology Research
Stock Symbol
IVA
Website
https://inventivapharma.comDescription
At Inventiva, we are united in developing differentiated treatments for MASH and making a meaningful difference in the lives of those affected. Recognizing that MASH is not just a liver disease but also a cardiometabolic condition, we have purposefully designed a potential oral therapy — currently in clinical development — intended to restore metabolic balance at the source and directly target inflammation and fibrosis. Our goal is to bring relief to patients across the MASH patient population, addressing a critical unmet need in a progressive and life-threatening disease. Our product candidate, lanifibranor, has been granted FDA Breakthrough Therapy Designation and is now being evaluated in a global Phase 3 clinical trial.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Inventiva Pharma and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.